Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
778 USD | -0,03% | +1,00% | +33,46% |
07:00 | Afspraken over afslankmedicijnen zorgen voor ongeveer 4% van de jaarlijkse groei van Gerresheimer, zegt CEO | RE |
28/03 | Sectorupdate: Gezondheidszorgaandelen stijgen aan het eind van de middag | MT |
ETF's gepositioneerd op Eli Lilly and Company
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
6.49% | 18 M€ | +6,77% | - | |
3.30% | 92 M€ | +0,06% | - | |
3.20% | 2 M€ | -.--% | - | |
3.19% | 9 M€ | -.--% | - | |
2.82% | 1 M€ | +11,94% | - | |
2.82% | 3 M€ | +7,32% | - | |
2.82% | 13 M€ | -.--% | - | |
2.71% | 5 M€ | -72,95% | - | |
2.58% | 786 M€ | -.--% | ||
2.58% | 23 M€ | -.--% | - | |
2.56% | 284 M€ | -.--% | ||
2.18% | 2 M€ | +14,69% | - | |
1.98% | 1 448 M€ | -.--% | - | |
1.98% | 219 M€ | +17,17% | - | |
1.96% | 36 M€ | -.--% | ||
1.95% | 2 M€ | +12,97% | ||
1.86% | 9 M€ | -4,31% | - | |
1.78% | 8 M€ | +6,91% | ||
1.70% | 1 M€ | +0,04% | ||
1.57% | 559 M€ | +14,30% | ||
1.57% | 1 848 M€ | +18,39% | - | |
1.49% | 273 M€ | -.--% | ||
1.49% | 655 M€ | -.--% | - | |
1.49% | 1 174 M€ | +23,54% | ||
1.46% | 414 M€ | +12,74% | - | |
1.46% | 1 006 M€ | -.--% | - | |
1.41% | 29 M€ | -.--% | - | |
1.41% | 322 M€ | +13,88% | - | |
1.21% | 276 M€ | +11,40% | - |
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,46% | 701 mld. | |
+26,24% | 570 mld. | |
+0,93% | 381 mld. | |
+21,03% | 334 mld. | |
+17,51% | 322 mld. | |
+0,74% | 209 mld. | |
+2,95% | 212 mld. | |
-6,05% | 205 mld. | |
-3,61% | 157 mld. | |
-1,28% | 152 mld. |
- Beurs
- Aandelen
- Aandeel Eli Lilly and Company - Nyse
- ETF's Eli Lilly and Company